Abstract
Mice were injected intraperitoneally (i.p.) with 300 mg of cyclophosphamide (CY)/kg of body weight, and 24 h later were injected i.p. with varying dosages of yeast-phase cells of Histoplasma capsulatum. At specific time intervals organs were removed, ground, and cultured to determine the number of viable organisms contained in the spleen, liver, and lungs. Injection of mice with CY was found to cause a dramatic increase in the numbers of parasites isolated from these organs when compared with non-drug-treated controls. Mice given 107 yeast cells showed the largest increase in colony numbers. A greater than fivefold increase in the numbers of organisms isolated from the spleens of CY and 103 yeast cell-treated mice, as compared with non-drug-treated animals, was observed at all time periods. The general trend for infected control animals was a decrease in colony numbers. All mice given CY plus 107 yeast cells intravenously (i.v.) died by day 20 postinfection. Mice given CY and 107 yeast cells i.p. showed no evidence of fatal Histoplasma infection. Deaths occurring by day 5 in CY-treated animals injected with H. capsulatum yeast cells i.v. or i.p. were considered due to bacterial infection or toxicity, or both. Hepatosplenomegaly was observed in mice treated with CY and 107 yeast cells of H. capsulatum. Enlarged lungs were also noted. CY control mouse spleens weighed 30% less than normal spleens. Organs of animals injected with H. capsulatum alone did not vary significantly from those of normal mice. Complete drug-induced suppression of humoral antibody response was achieved for 10 days, as determined by hemagglutination titrations.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ADLER F. L. STUDIES ON MOUSE ANTIBODIES. I. THE RESPONSE TO SHEEP RED CELLS. J Immunol. 1965 Jul;95:26–38. [PubMed] [Google Scholar]
- ARNOLD H., BOURSEAUX F., BROCK N. Chemotherapeutic action of a cyclic nitrogen mustard phosphamide ester (B 518-ASTA) in experimental tumours of the rat. Nature. 1958 Mar 29;181(4613):931–931. doi: 10.1038/181931a0. [DOI] [PubMed] [Google Scholar]
- Adamson D. M., Cozad G. C. Effect of antilymphocyte serum on animals experimentally infected with Histoplasma capsulatum or Cryptococcus neoformans. J Bacteriol. 1969 Dec;100(3):1271–1276. doi: 10.1128/jb.100.3.1271-1276.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aisenberg A. C. Studies on cyclophosphamide-induced tolerance to sheep erythrocytes. J Exp Med. 1967 May 1;125(5):833–845. doi: 10.1084/jem.125.5.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aisenberg A. C., Wilkes B. Immunological tolerance induced by cyclophosphamide assayed by plaque spleen cell method. Nature. 1967 Feb 4;213(5075):498–499. doi: 10.1038/213498a0. [DOI] [PubMed] [Google Scholar]
- BERENBAUM M. C., BROWN I. N. DOSE-RESPONSE RELATIONSHIPS FOR AGENTS INHIBITING THE IMMUNE RESPONSE. Immunology. 1964 Jan;7:65–71. [PMC free article] [PubMed] [Google Scholar]
- Cozad G. C., Scalarone G. M. Effect of histoplasmosis on antibody response to an erythrocyte antigen. J Bacteriol. 1969 Feb;97(2):576–580. doi: 10.1128/jb.97.2.576-580.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FOX M. SUPPRESSION OF TISSUE IMMUNITY BY CYCLOPHOSPHAMIDE. Transplantation. 1964 Jul;2:475–486. doi: 10.1097/00007890-196407000-00004. [DOI] [PubMed] [Google Scholar]
- FRISCH A. W., DAVIES G. H. INHIBITION OF HEMAGGLUTININ SYNTHESIS BY CYTOXAN. Cancer Res. 1965 Jun;25:745–751. [PubMed] [Google Scholar]
- Frisch A. W., Davies G. H. Inhibition of hemagglutin synthesis by cytoxan: specificity and drug-induced "tolerance". J Lab Clin Med. 1966 Jul;68(1):103–112. [PubMed] [Google Scholar]
- HILL R. B., Jr, ROWLANDS D. T., Jr, RIFKIND D. INFECTIOUS PULMONARY DISEASE IN PATIENTS RECEIVING IMMUNOSUPPRESSIVE THERAPY FOR ORGAN TRANSPLANTATION. N Engl J Med. 1964 Nov 12;271:1021–1027. doi: 10.1056/NEJM196411122712001. [DOI] [PubMed] [Google Scholar]
- HUTER R. V., COLLINS H. S. The occurrence of opportunistic fungus infections in a cancer hospital. Lab Invest. 1962 Nov;11:1035–1045. [PubMed] [Google Scholar]
- Larsh H. W., Cozad G. C. Respiratory infection of mice with Histoplasma capsulatum. Mycopathol Mycol Appl. 1965 Dec 1;27(3):305–310. doi: 10.1007/BF02053788. [DOI] [PubMed] [Google Scholar]
- Owens A. H., Jr, Santos G. W. The induction of graft versus host disease in mice treated with cyclophosphamide. J Exp Med. 1968 Aug 1;128(2):277–291. doi: 10.1084/jem.128.2.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ROWLEY D. A., HUBER M. Growth of Histoplasma capsulatum in normal, superinfected, and immunized mice. J Immunol. 1956 Jul;77(1):15–23. [PubMed] [Google Scholar]
- Reiner J., Southam C. M. Effect of immunosuppression on first-generation isotransplantation of chemically induced tumours in mice. Nature. 1966 Apr 23;210(5034):429–430. doi: 10.1038/210429a0. [DOI] [PubMed] [Google Scholar]
- SALVIN S. B. Cultural and serologic studies on nonfatal histoplasmosis in mice, hamsters, and guinea pigs. J Infect Dis. 1954 Jan-Feb;94(1):22–29. doi: 10.1093/infdis/94.1.22. [DOI] [PubMed] [Google Scholar]
- SEVER J. L. Application of a microtechnique to viral serological investigations. J Immunol. 1962 Mar;88:320–329. [PubMed] [Google Scholar]
- Santos G. W., Owens A. H., Jr 19S and 17S antibody production in the cyclophosphamide- or methotrexate-treated rat. Nature. 1966 Feb 5;209(5023):622–624. doi: 10.1038/209622a0. [DOI] [PubMed] [Google Scholar]
- Sharbaugh R. J., Grogan J. B. Suppression of reticuloendothelial function in the rat with cyclophosphamide. J Bacteriol. 1969 Oct;100(1):117–122. doi: 10.1128/jb.100.1.117-122.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
